A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease

BACKGROUND: Depressive symptoms are the most common neuropsychiatric symptoms in patients with Alzheimer’s disease (AD). However, despite being common, no definite consensus recommendations exist for the management of depression in AD. OBJECTIVE: To assess the effects of selective serotonin reuptake...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinli, Zheng, Xiaohui, Zhao, Zhenying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230772/
https://www.ncbi.nlm.nih.gov/pubmed/37259037
http://dx.doi.org/10.1186/s12883-023-03191-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230772/
https://www.ncbi.nlm.nih.gov/pubmed/37259037
http://dx.doi.org/10.1186/s12883-023-03191-w

Ejemplares similares